Evaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertension

In an effort to understand the origin of blood-pressure lowering effects observed in recent clinical trials with 11β-HSD1 inhibitors, we examined a set of 11β-HSD1 inhibitors in a series of relevant in vitro and in vivo assays. Select 11β-HSD1 inhibitors reduced blood pressure in our preclinical models but most or all of the blood pressure lowering may be mediated by a 11β-HSD1 independent pathway.     

中国二种盗蛛的分类研究(蜘蛛目:盗蛛科)

本文对我国两种盗蛛：马蹄潮蛛Hygropoda hippocrepiforma Wang,1993和带形盗蛛Pisaura zonaformis Wang,1993的分类地位进行了修订。研究结果表明,马蹄溯蛛Hygropoda hippocrepiforma Wang,1993为长肢溯蛛Hygropoda higenaga(Kishida,1936)的新异名,移带形盗蛛Pisaura zonaformis Wang ,1993到东洋蛛属Polyboea,该属亦为我国新记录属。     

尖孢镰刀菌(Fusarium oxysporum)诱导矿化回收稀土离子La(Ⅲ)

[目的] 从罗源湾红树林浅滩土壤中筛选出产脲酶真菌,研究其对镧La（Ⅲ）的最大耐受浓度,利用其吸附和产脲酶作用诱导矿化回收稀土离子La（Ⅲ）,以期为稀土离子La（Ⅲ）的资源回收提供菌种资源和应用技术指导。[方法] 从罗源湾红树林浅滩土壤中分离、筛选、纯化出可产脲酶及耐La（Ⅲ）真菌,通过ITS rDNA基因序列分析对其进行鉴定;同时,利用XRD、SEM-Mapping及FT-IR分析探讨菌株回收La（Ⅲ）的机理。[结果] 经分离、纯化得到一株可产脲酶及耐受高浓度La（Ⅲ）的真菌FZU-07,鉴定为尖孢镰刀菌（Fusarium oxysporum）,其具有较强诱导矿化回收La（Ⅲ）的能力,对La（Ⅲ）的最大耐受浓度为400 mg/L。菌株FZU-07单独对La（Ⅲ）吸附回收效率为46.19%;在诱导矿化条件下回收效率可提高到99.16%。FT-IR和SEM-Mapping分析表明,尖孢镰刀菌吸附La（Ⅲ）与菌丝体表面的氨基、羟基、羰基和磷酸基团相关;XRD和SEM-Mapping结果表明诱导矿化是通过该菌的产脲酶特性,使尿素分解产生碳酸,并与钙离子结合生成球霰石晶型的碳酸钙,La（Ⅲ）被捕获在球霰石晶格中,形成La（Ⅲ）和碳酸钙的混合固相,以共沉淀的形式被回收。[结论] 菌株FZU-07,是一株具有产脲酶特性的尖孢镰刀菌（Fusarium oxysporum）,且具有较强的诱导矿化回收La（Ⅲ）能力。表明微生物诱导碳酸钙沉淀是一种可行且生态友好的回收稀土离子的方法。     

A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia

Inflammation may play a major role in the pathogenesis of preeclampsia (PE). In this meta-analysis, we determined whether maternal polymorphisms and serum concentrations of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-10 (IL-10) were associated with PE. All studies investigating the associations between PE and maternal polymorphisms of TNF-α-308G/A, IL-6-174G/C, and IL-10-1082A/G or serum concentrations of TNF-α, IL-6, and IL-10 were reviewed. We found that neither maternal TNF-α-308G/A (p=0.86, odds ratio [OR]=0.98, 95% confidence interval [CI], 0.76-1.25), IL-6 174G/C (p=0.14, OR=1.23, 95% CI, 0.93-1.61), nor IL-10-1082A/G (p=0.72, OR=1.07, 95% CI, 0.75-1.52) were associated with PE. On the other hand, maternal TNF-α (p<0.00001, weighted mean difference [WMD]=19.63 pg/ml, 95% CI, 18.54-20.72 pg/ml), IL-6 (p<0.00001, WMD=6.58 pg/ml, 95% CI, 5.49-7.67 pg/ml), and IL-10 (p=0.0005, WMD=19.30 pg/ml, 95% CI, 8.42-30.17 pg/ml) concentrations were significantly higher in PE patients versus controls. Our findings strengthen the clinical evidence that PE is accompanied by exaggerated inflammatory responses, but do not support TNF-α-308G/A, IL-6-174G/C, and IL-10-1082A/G as candidate susceptibility loci in PE.     

High‐Temperature Shock Enabled Nanomanufacturing for Energy‐Related Applications

Functional nanomaterials are playing a crucial role in the emerging field of energy‐related devices. Recently, as a novel synthesis method, high‐temperature shock (HTS), which is rapid, low cost, eco‐friendly, universal, scalable, and controllable, has provided a promising option for the rational design and synthesis of various high‐quality nanomaterials. In this report, the HTS technique, including the equipment setup and operating principle, is systematically introduced, and recent progress in the synthesis of nanomaterials for energy storage and conversion applications using this HTS method is summarized. The growth mechanisms of nanoparticles and carbonaceous nanomaterials are thoroughly discussed, followed by the summary of the characteristic advantages of the HTS strategy. A series of nanomaterials prepared by the HTS method, including carbon‐based films, metal nanoparticles and compound nanoparticles, show high performance in the diverse applications of storage energy batteries, highly active catalysts, and smart energy devices. Finally, the future perspectives and directions of HTS in nanomanufacturing for broader applications are presented.